2nd Quarter - Report

ALLERGAN, INC. for ALLERGAN, INC.

Period 2nd Quarter 2014 Filed Jul 21, 2014 Signed by JENNIE UNGER SKELTON, ATTORNEY & AGENT FOR FILER

Official filing
Firm
ALLERGAN, INC.
Client
ALLERGAN, INC.
Income
—
Expenses
$550,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Labor Issues/Antitrust/Workplace LBR

GENERAL ISSUES RELATED TO TO THE HOSTILE ACQUISITION ATTEMPT ON ALLERGAN

LobbyistCovered position, as disclosed
EDWARD C RENO N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

FOOD AND DRUG ADMINISTRATION (FDA) REGULATION ON RESTASIS DRY DRAFT GUIDANCE GENERAL ISSUES RELATED TO TO THE HOSTILE ACQUISITION ATTEMPT ON ALLERGAN

LobbyistCovered position, as disclosed
EDWARD C RENO N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.